Leading the way in de-risking clinical development with Al

Request a Demo

The Pharmaceutical Industry Is Ready for a Breakthrough

With our suite of solutions, de-risk and enhance clinical development and decision-making with the power of artificial intelligence.

Measure the likelihood of success for drugs across multiple therapeutic areas

Bolster internal risk identification with accurate AI-driven assessments

Pinpoint underlying drivers contributing to technical and regulatory risk

Explore risks influencing the drug development pipeline

Review the competitive landscape for acquisition, licensing and portfolio strategies

Detect predictive signals and optimize clinical trial design

Standardize risk evaluation processes across entire portfolios

Access a single source of quality, harmonized data for consistent risk evaluation

Make More Confident Decisions With
AI You Can Trust

Eliminate the all-too-common mysterious AI black box. Make more confident decisions with trusted AI, where there’s transparency behind which features drive the algorithm’s results to help answer the “how” and the “why.”

As emerging science and technology bring new possibilities for innovation—and sophistication – Intelligencia AI is poised to help you drive operational and decision-making excellence throughout your organization.

Discover More

AI-Powered Solutions Built With Comprehensive, Precise Data

Real-time tracking of clinical programs and features organized by proprietary ontologies

Expert data curation
and quality control by
biomedical professionals

Trusted by leading
pharma organizations
over legacy data sources
for PTRS/PoS calculations 

icon-trusted-2@2x

Proven AI Accuracy With Advanced Algorithms

Accurate PTRS assessments validated retrospectively and prospectively at all clinical development stages

Actively tracked and validated real-world predictions

High prospective accuracy (>80%) vs. retrospective-only analyses of AI models 

State-of-the-Art Explainable AI and Transparency

Transparency into PTRS predictions with hundreds of dimensions

Visualization of the drivers of PTRS predictions

Continuous innovation and investment with partner and customer feedback

Many of the top global pharma companies work with us. Want to join them?

Let’s Talk

Here's What Your Peers Have Shared

We did our competitive landscaping exercise and we are not aware of any other dataset that has been custom- built to address development risk.

—Director, Global Pharmaceutical Company

You are sitting on a goldmine.

—Head of Statistics in Oncology

Thank you for informing and enabling our portfolio strategy with a continuous stream of insights across emerging trends and salient competitive threats in our space.

—VP of Portfolio Strategy, Biotech

Intelligencia Al has always taken a very thoughtful and rigorous process on everything you do and it is a great pleasure to work with you.

—Decision Analysis, Global Pharmaceutical Company

Linkedin

© Intelligencia AI. All rights reserved.